Cover Image

A phase 2 trial to evaluate the effects of 3BNC117 in addition to antiretroviral therapy on the latent reservoir and viral rebound

Saved in:

Bibliographic Details
Main Authors:	J. Lorenzi (Author), Y. Cohen (Author), L. Burke (Author), M. Caskey (Author), M. Nussenzweig (Author)
Format:	Book
Published:	Elsevier, 2017-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

OP 7.2 - 00035 Impact of 10-1074LS and 3BNC117-LS on viral rebound dynamics following treatment interruption six months after dosing: four cases from the open label arm of the RIO trial
by: M. Lee, et al.
Published: (2022)

OP 1.9 - 00042 Measuring the impact of early 3BNC117 intervention at ART initiation on the productive reservoir in a cohort of diverse viral subtypes: results from the VIP-SPOT assay in the eCLEAR trial
by: M.C. Puertas, et al.
Published: (2022)

Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV
by: A.L. Hill, et al.
Published: (2015)

Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled study
by: Sofie Rutsaert, et al.
Published: (2019)

Dual-affinity re-targeting (DART) proteins overcome viral diversity to deplete the latent HIV-1 reservoir
by: J.M. Sung, et al.
Published: (2015)

Barcoded viruses facilitate tracking changes to the composition of the rebound-competent reservoir
by: B. Keele, et al.
Published: (2019)

Latent HIV dynamics and implications for sustained viral suppression in the absence of antiretroviral therapy
by: John M. Murray
Published: (2018)

19 Quantification and correlates of the replication competent HIV-1 latent viral reservoir in a virally suppressed Ugandan population
by: J.L. Prodger, et al.
Published: (2016)

Understanding persistence of the latent reservoir
by: R.F. Siliciano
Published: (2017)

Sex differences in the latent reservoir of virally suppressed HIV-1 infected individuals living in Rakai, Uganda
by: T.C. Quinn, et al.
Published: (2019)

PP 4.10 - 00119 Multiomic dynamics of the cellular HIV reservoir after rebound during ATI
by: V. Wu, et al.
Published: (2022)

PP 2.12 - 00153 eCD4-Ig-DNA Decreased HIV Reservoir and Delayed Viral Rebound Through Fc Mediated Functions in BLT Humanized Mice
by: Z. Yuan, et al.
Published: (2022)

Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint
by: M. Abdel-Mohsen, et al.
Published: (2019)

Intact and replication-competent reservoir virus populations differ from each other and rebound plasma viruses
by: K. Bar, et al.
Published: (2019)

Tissue macrophages are a major viral reservoir in male urethra of HIV-1-infected individuals under suppressive antiretroviral therapy
by: M. Bomsel, et al.
Published: (2017)

HIV-1 in the latent reservoir is largely sensitive to circulating T cells
by: J. Warren, et al.
Published: (2019)

PP 8.11 - 00174 Distinct HIV reservoir characteristics among individuals treated during primary versus chronic HIV infection
by: C. Bittar Oliva, et al.
Published: (2022)

11 Murine model to predict viral rebound in HIV+ allotransplanted subjects
by: Maria Salgado, et al.
Published: (2017)

Effect of natural killer cells on viral rebound in HIV-1-infected humanized mice
by: J. Kim, et al.
Published: (2019)

PP 4.5 - 00064 Differentiation Enhances Reactivation of Latent HIV-1 Reservoir in CD4+ T Cells in PLWH With > 4 Years of Viral Suppression
by: Y. Kuzmichev, et al.
Published: (2022)

CD32 does not mark the HIV-1/SIV latent reservoir
by: C.E. Osuna, et al.
Published: (2017)

Barcoded HIV reveals effects of PKC modulation on viral reservoir
by: J. Zack, et al.
Published: (2019)

BCL-2 inhibitor sensitizes the latent HIV reservoir to elimination by CTLs
by: S.-H. Huang, et al.
Published: (2017)

Brief ATI does not alter the size or composition of the latent HIV-1 reservoir
by: K.J. Bar, et al.
Published: (2017)

Rate of HIV rebound and CD4 T cell kinetics in an ageing population on successful antiretroviral therapy
by: Abhishek Katiyar, et al.
Published: (2018)

Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption
by: You Park, et al.
Published: (2017)

Implicações da BNC-formação para a universidade pública e formação docente
by: Eliane Miranda Costa, et al.
Published: (2021)

PP 4.24 - 00176 Impact of cannabis use on immune cell populations and the viral reservoir in HIV-infected people on suppressive antiretroviral therapy
by: Shane D. Falcinelli, et al.
Published: (2022)

4 Post-treatment control or treated controllers? The impact of ART on time to viral rebound in recent seroconverters
by: G.E. Martin, et al.
Published: (2016)

Differential viral rebound between lymph node and colon after treatment interruption in SHIV-infected rhesus macaques
by: D.C. Hsu, et al.
Published: (2017)

Viral load and rebound in children with coronavirus disease 2019 during the first outbreak in Daegu city
by: Mi Ae Chu, et al.
Published: (2021)

Quantitation of the CD4+ T cell and macrophage reservoirs in SIV-infected ART-suppressed macaques: two functional latent reservoirs
by: J. Clements, et al.
Published: (2017)

Future approaches to clearing the latent human immunodeficiency virus reservoir: Beyond latency reversal
by: Alexander M.L. Hayes
Published: (2020)

Marked variation in the susceptibility of HIV-1 to type 1 interferon inhibition during early, late and rebound infection
by: M. Gondim, et al.
Published: (2019)

PP 4.11 - 00126 Autologous Neutralizing Antibodies Increase with Early Antiretroviral Therapy and Shape HIV Rebound after Treatment Interruption
by: E. Esmaeilzadeh, et al.
Published: (2022)

117TH CONGRESS OF PAEDIATRICIANS
Published: (2014)

117TH CONGRESS OF PAEDIATRICIANS
Published: (2014)

OP 7.3 - 00139 Pre-treatment Interruption Plasma Metabolites and Glycans Correlate with Time to HIV Rebound and Reservoir Size in ACTG A5345
by: L.B. Giron, et al.
Published: (2022)

Viral rebound and safety of nirmatrelvir/ritonavir for lung-transplant recipients infected with SARS-CoV-2
by: Hui Li, et al.
Published: (2023)

BNCC E BNC-formação: consequências na formação de professores para as escolas do campo
by: Mauro Titton
Published: (2022)